Biblio

33557 resultats trouvés
A
Nivelle L, Hubert J, Courot E, Jeandet P, Aziz A, Nuzillard J-M, Renault J-H, Clement C, Martiny L, Delmas D et al..  2017.  Anti-Cancer Activity of Resveratrol and Derivatives Produced by Grapevine Cell Suspensions in a 14 L Stirred Bioreactor. MOLECULES. 22:474.
Ali M, Dondaine L, Adolle A, Sampaio C, Chotard F, Richard P, Denat F, Bettaieb A, Le Gendre P, Laurens V et al..  2015.  Anticancer Agents: Does a Phosphonium Behave Like a Gold(I) Phosphine Complex? Let a ``Smart'' Probe Answer! JOURNAL OF MEDICINAL CHEMISTRY. 58:4521-4528.
Apetoh L.  2020.  Anticancer effects of the microbiota: how the microbiome shapes the development of IL-9-producing T cells. BRITISH JOURNAL OF CANCER. 123:497-498.
Apetoh L.  2020.  Anticancer effects of the microbiota: how the microbiome shapes the development of IL-9-producing T cells. BRITISH JOURNAL OF CANCER. 123:497-498.
Aldebert G., Faillie J.L, Hillaire-Buys D., Mura T., Carriere I., Delcourt C., Creuzot-Garcher C., Villain M., Daien V..  2018.  Anticholinergic drug use and risk for age-related macular degeneration: a case-control study. FUNDAMENTAL & CLINICAL PHARMACOLOGY. 32:44.
Chapuis J, Siu-Paredes F, Pavageau C, Amador G, Rude N, Denis F.  2020.  Anticholinergic drugs and oral health-related quality of life in patients with schizophrenia: a pilot study. TRANSLATIONAL NEUROSCIENCE. 11:10-16.
Callegari B, Saunieri G, Duarte MBrito, Almeida GCristina d, Amorim CFerreira, Mourey F, Pozzo T, Souza Gda Silva.  2018.  Anticipatory Postural Adjustments and kinematic arm features when postural stability is manipulated. PEERJ. 6:e4309.
Nogueira-Campos A.A, Hilt P.M, Fadiga L., Veronesi C., D'Ausilio A., Pozzo T..  2019.  Anticipatory postural adjustments during joint action coordination. SCIENTIFIC REPORTS. 9:12328.
Hanon O, Jeandel C, Jouanny P, Paccalin M, Puisieux F, Krolak-Salmon P, Berrut G.  2019.  Anticoagulant treatment in patients with atrial fibrillation: position paper. GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT. 17:341-355.
Chocron R, Galand V, Cellier J, Gendron N, Pommier T, Bory O, Khider L, Trimaille A, Goudot G, Weizman O et al..  2021.  Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study. JOURNAL OF THE AMERICAN HEART ASSOCIATION. 10:e018624.
Yan X, Yan W, Zhang L.  2018.  Anti-Congestion Algorithm for Multiple Data Unicast Transmission in the Internet of Brain Things. IEEE ACCESS. 6:75718-75728.
Peanlikhit T, Van Waes V, Pedron S, Risold P-Y, Haffen E, Etievant A, Monnin J.  2017.  The antidepressant-like effect of tDCS in mice: A behavioral and neurobiological characterization. BRAIN STIMULATION. 10:748-756.
Belhadj S, Keskes H, Apel C, Roussi F, Litaudon M, Hentati O, Allouche N.  2020.  Anti-diabetic and lipid-lowering effects of drimane sesquiterpenoids isolated from Zygogynum pancheri. CHEMICO-BIOLOGICAL INTERACTIONS. 330:109167.
Zuily S, de Laat B, Guillemin F, Kelchtermans H, Magy-Bertrand N, Desmurs-Clavel H, Lambert M, Poindron V, De Maistre E, Dufrost V et al..  2020.  Anti-Domain I beta(2)-Glycoprotein I Antibodies and Activated Protein C Resistance Predict Thrombosis in Antiphospholipid Syndrome: TAC(I)T Study. JOURNAL OF APPLIED LABORATORY MEDICINE. 5:1242-1252.
Pouliquen E., Baltzinger P., Lemle A., Chen C., Parissiadis A., Borot S., Frimat L., Girerd S., Berney T., Lablanche S. et al..  2017.  ANTI-DONOR HLA ANTIBODY RESPONSE AFTER PANCREATIC ISLET GRAFTING: CHARACTERISTICS, RISK FACTORS AND IMPACT ON GRAFT FUNCTION. TRANSPLANT INTERNATIONAL. 30:14.
Pouliquen E., Baltzinger P., Lemle A., Chen C.-C, Parissiadis A., Borot S., Frimat L., Girerd S., Berney T., Lablanche S. et al..  2017.  Anti-Donor HLA Antibody Response After Pancreatic Islet Grafting: Characteristics, Risk Factors, and Impact on Graft Function. AMERICAN JOURNAL OF TRANSPLANTATION. 17:462-473.
Pouliquen E., Baltzinger P., Lemle A., Chen C., Parissiadis A., Borot S., Frimat L., Girerd S., Berney T., Lablanche S. et al..  2017.  ANTI-DONOR HLA ANTIBODY RESPONSE AFTER PANCREATIC ISLET GRAFTING: CHARACTERISTICS, RISK FACTORS AND IMPACT ON GRAFT FUNCTION. TRANSPLANT INTERNATIONAL. 30:14.
Vendrely V, Lemanski C, Gnep K, Barbier E, Hajbi FEl, Lledo G, Dahan L, Terrebonne E, Manfredi S, Mirabel X et al..  2019.  Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: Results of a phase I dose-escalation study with panitumumab (FFCD 0904). RADIOTHERAPY AND ONCOLOGY. 140:84-89.
Aparicio T, Ronchin P, Bazire L, Le Malicot K, Lemanski C, Mirabel X, Etienne P-L, Lievre A, Cacheux W, Darut-Jouve A et al..  2019.  Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: Results of a phase II study with panitumumab (FFCD 0904).. JOURNAL OF CLINICAL ONCOLOGY. 37
Vendrely V., Ronchin P., Le-Malicot K., Minsat M., Lemanski C., Mirabel X., Lievre A., Darut-Jouve A., de la Fouchardiere C., Breysacher G. et al..  2021.  Anti-Epidermal Growth Factor Receptor Therapy in combination with Chemoradiotherapy for the Treatment of Locally Advanced Anal Canal Carcinoma: Results of a Phase II Study with Panitumumab (FFCD 0904). RADIOTHERAPY AND ONCOLOGY. 161:S82-S83.
Bellaye P-S, Burgy O, Colas J, Fabre A, Marchal-Somme J, Crestani B, Kolb M, Camus P, Garrido C, Bonniaud P.  2015.  Antifibrotic Role of alpha B-Crystallin Inhibition in Pleural and Subpleural Fibrosis. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY. 52:244-252.
Condelier K, Thevenon M-F, Collet R, Gerardin P, Dumarcay S.  2020.  ANTI-FUNGAL AND ANTI-TERMITE ACTIVITY OF EXTRACTIVES COMPOUNDS FROM THERMALLY MODIFIED ASH WOODS. MADERAS-CIENCIA Y TECNOLOGIA. 22:223-240.
Michallet M, Sobh M, Deloire A, Raffoux E, de Botton S, Caillot D, Reman O, Girault S, Berthon C, Huguet F et al..  2016.  Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy. Prospective Observational Study from the Acute Leukemia French Association (ALFA) Group. BLOOD. 128
Gangneux J.-P, El-Cheikh J., Herbrecht R., Yakoub-Agha I., Caillot D., Michallet M..  2015.  ANTIFUNGAL PROPHYLAXIS IN HAEMATOLOGY PATIENTS: FREQUENCY AND DRUG CLASS OF CHOICE ACCORDING TO TYPE OF HAEMATOLOGICAL MALIGNANCY (AFHEM STUDY). HAEMATOLOGICA. 100:294.
Bellanger A-P, Persat F., Foulet F., Bonnal C., Accoceberry I, Angebault C., Angoulvant A., Augereau O., Bailly E., Bert F. et al..  2020.  Antifungal susceptibility testing practices in mycology laboratories in France, 2018. JOURNAL DE MYCOLOGIE MEDICALE. 30:100970.

Pages